Close

Bristol-Myers Squibb (BMY) , Pfizer (PFE) Announce Encouraging Post-Hoc Data from Phase 3 AMPLIFY in VTE

December 10, 2015 4:25 PM EST Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced results from a post-hoc early time course subanalysis of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login